India to Indonesia: Vaccine Export Trade Route

The India to Indonesia Vaccine corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $46.3M USD. The route is dominated by BHARAT BIOTECH INTERNATIONAL LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's vaccine manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $984.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with vaccine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 21.1%, placing it at rank #15 among India's top vaccine export destinations globally.

On the import side, key buyers of Indian vaccine in Indonesia include PT BIO FARMA PERSERO NA, PT BIO FARMA (PERSERO), PT BIO FARMA PERSERO JL PASTEUR and 16 others. PT BIO FARMA PERSERO NA is the single largest importer with 2 shipments valued at $12.0M USD.

India's vaccine exports to Indonesia are driven primarily by a handful of large-scale manufacturers. BHARAT BIOTECH INTERNATIONAL LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Indonesia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BHARAT BIOTECH INTERNATIONAL LIMITED, BIOLOGICAL E. LIMITED, BRILLIANT BIO PHARMA PRIVATE LIMITED — together account for 91% of total trade value on this route. The average shipment value of $984.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as rotavac 2.5 ml rotavirus vaccine liveoral foc: rotavac 2.5 ml qty: 1428 vls droppers qty: 692800 nos and rotavac 2.5 ml rotavirus vaccine liveoral, suggesting that buyers in Indonesia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PT BIO FARMA PERSERO NA is the largest importer with 2 shipments worth $12.0M USD — representing 26% of all vaccine imports from India on this route. A total of 19 buyers are active on this corridor.